We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Ariadne’s PathwayStudio® 4.0 Earns GeneChip-compatible™ Status

Ariadne’s PathwayStudio® 4.0 Earns GeneChip-compatible™ Status

Ariadne’s PathwayStudio® 4.0 Earns GeneChip-compatible™ Status

Ariadne’s PathwayStudio® 4.0 Earns GeneChip-compatible™ Status

Read time:

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Ariadne’s PathwayStudio® 4.0 Earns GeneChip-compatible™ Status"

First Name*
Last Name*
Email Address*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Ariadne Genomics, Inc. has announced that it has joined the Affymetrix GeneChip-compatible Applications Program, which is designed to provide customers with a broad spectrum of software solutions for biomedical research and development.

Ariadne’s PathwayStudio® 4.0 pathway analysis software has earned GeneChip-compatible™ status.

As a GeneChip-compatible software provider, Ariadne is committed to integrating their entire pathway analysis product pipeline with the Affymetrix GeneChip technology.

PathwayStudio 4.0 (formerly marketed as PathwayAssist) allows life scientists to analyze and interpret gene expression microarray data in the context of biological pathways and to reconstruct regulatory networks from gene expression experiments.

The software comes with a database of over 1,000,000 molecular interaction facts extracted from the scientific literature and over 1,000 reconstructed pathways.

"We are delighted that PathwayStudio 4.0 has achieved GeneChip-compatible status with Affymetrix," said Dr. Ilya Mazo, president of Ariadne.

"Ariadne’s mission is to provide life scientists with tools and solutions to stimulate biomedical research and drug development."

"The integration between PathwayStudio and the Affymetrix GeneChip microarray platform is yet another vital milestone in the realization of our goal."

"Pathway-level annotation and functional analysis is fast becoming a standard part of gene expression microarray data analysis," said Steve Lincoln, vice president of Informatics at Affymetrix.

"The integration between the Affymetrix GeneChip platform and Ariadne’s PathwayStudio allows our mutual customers to extract the greatest value from their microarray data."